- 2023 Multidisciplinary Oncology Review
- 2022
- Videos
- 2021
- 2020
- 2019
- Hematology & Medical Oncology Review 2019
- 2018
- Events
Playback speed
10 seconds
KU ASCO 2019 Targeted Therapy Drugs for AML - CPX-351, FLT3, IDH Inhibitors, BCL-2, & Hedgehog Pathway Inhibitor
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
0 views
August 19, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Malignancies